Q&A: Pharmacist Highlights Challenges in Vaccine Information Navigation Amid Changing Recommendations
Drug Topics
JULY 2, 2025
This schedule also helped dictate insurance coverage of those recommended vaccines.
Drug Topics
JULY 2, 2025
This schedule also helped dictate insurance coverage of those recommended vaccines.
Drug Topics
JULY 6, 2025
She warned that changes in vaccine recommendations could impact insurance coverage, patient access, and ultimately public health, particularly for vulnerable populations like low-income children.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JULY 15, 2025
They will have insurance coverage, and that has helped tremendously to be able to adjust insulin doses. We have seen that explode, really kind of side by side with the GLP-1 medications to the point where now anyone on insulin, any type of insulin, even just a once-a-day, long-acting insulin, typically now has access to CGM.
Drug Topics
JUNE 25, 2025
Despite a high prevalence of childhood and youth-aged obesity, the use of medications for treating obesity is persistently low among children and young adults (YA), according to an abstract presented at the American Diabetes Association’s 85th Scientific Sessions, held in Chicago, Illinois, from June 20-23, 2025. Accessed June 25, 2025.
The Checkup by Singlecare
JUNE 5, 2025
Insurance often does come through if the prescription is for diabetes management, not weight loss. However, insurance coverage depends on the insurance company and plan. That’s because insurance coverage varies by plan. Some Aetna enrollees receive coverage for Mounjaro. Does Aetna cover Mounjaro?
pharmaphorum
JUNE 12, 2025
These closures, compounded by the decline of independent pharmacies, create a critical gap in care. True visibility comes from layering pharmacy locations on top of geospatial data, such as population density, income levels, transportation access, insurance coverage, and health burden.
Drug Topics
JUNE 25, 2025
Investigators find that current practices among pharmacists are not fully in alignment with American Diabetes Association (ADA) guideline recommendations for glucagon use, with frequently identified barriers including cost, patient health literacy, and insurance coverage.
Let's personalize your content